FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA OKs Synapse Bio PMA for Breathing System

FDA approves a Synapse Biomedical PMA for the NeuRx Diaphragm Pacing System for use in patients with spinal cord injuries who rely on mechanical venti...

latest-news-card-1
Federal Register

NADA Human Safety Assessment Guide

Federal Register notice: FDA announces the availability of a draft guidance entitled Human User Safety (HUS) in New and Abbreviated New Animal Drug Ap...

latest-news-card-1
Human Drugs

Endpoint Clinical Outcome Assessment Guidance

FDA publishes the last in a series of four guidances on aspects of patient-focused drug development.

latest-news-card-1
Medical Devices

3 Ex-Magellan Officials Charged Over Device Malfunctions

The Justice Department charges three former top officials at Magellan Diagnostics over their role in allegedly concealing a device malfunction that pr...

latest-news-card-1
Human Drugs

Multiple Violations in Aspire Pharma Inspection

FDA warns Somerset, NJ-based Aspire Pharmaceuticals about multiple violations in its production of dietary supplements and human drugs.

latest-news-card-1
Human Drugs

Withdraw Wakix Approval: Scorpion Capital Petition

Scorpion Capital says its research into deaths and adverse events associated with Harmony Biosciences narcolepsy drug Wakix indicates FDA should withd...

latest-news-card-1
Human Drugs

OCP IND Prioritization, Triage Guidance

CDER issues an updated MAPP for Office of Clinical Pharmacology IND review processes.

latest-news-card-1
Animal Drugs

Guide on Animal Drug Human Safety Assessments

FDA posts a draft guidance entitled Human User Safety in New and Abbreviated New Animal Drug Applications to inform sponsors of the types of informati...

Medical Devices

Abbott Safety Notice on FreeStyle Libre Readers

Abbott issues a safety notice for the Readers and batteries used as part of the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash g...

latest-news-card-1
Human Drugs

Tavo-EP/Keytruda Fails Phase 2 Melanoma Trial

OncoSec says its Tavo-EP in combination with Mercks Keytruda failed to meet the overall response rate primary endpoint in a Phase 2 trial with some me...